Are We Ready for the Moonshot?
NCCN Policy Summit to Address the State of HIT June 27 in Washington, D.C.
FORT WASHINGTON, PA — White House Cancer Task Force Executive Director Gregory Simon will join a broad array of stakeholders at the National Comprehensive Cancer Network® (NCCN®) Policy Summit: Emerging Issues and Opportunities in Health Information Technology to address the state of health information technology (HIT), including the role and readiness of HIT systems in implementing the National Cancer Moonshot Initiative. The summit will take place at The National Press Club in Washington, D.C. on Monday, June 27, 2016, from 8:30 AM – 3:30 PM. For press credentials, contact NCCN Communications Manager Katie Kiley Brown at brown@nccn.org.
Clinical cancer care, related quality initiatives, and emerging coverage models for care continue to evolve; how ready is Health Information Technology (HIT) to support this shifting landscape and other advances, such as personalized medicine? Of issue include a lack of interoperability between systems, varying complexities of systems, and issues of proprietary interest limit the understanding and exchange of information across systems and stakeholders. Panelists will discuss these issues, their role in the cancer care continuum, how they interact with HIT systems, and ultimately how they are developing solutions necessary to move beyond meaningful to make gains in precision medicine and quality care.
This policy summit will gather the many stakeholders—clinicians, government and regulatory organizations, patient advocacy groups, pharma-biotech companies, providers, and HIT companies and vendors—who are crucial to understand the challenges and opportunities in utilizing HIT to improve cancer care.
Clifford Goodman, PhD, of The Lewin Group will moderate the summit, which will consist of short presentations followed by roundtable discussions with lively discourse and ample time for audience questions. An abbreviated agenda is below.
As developers of widely used NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) that set standards for cancer treatment in the United States and abroad, NCCN is invested in supporting the provision of high-quality, value-based cancer care. In addition to hosting this timely conversation about the emerging role of HIT, NCCN is committed to digitizing its products and ensuring their functionality across multiple HIT systems so that patients with cancer have access to appropriate care.
Agenda[i]:
Welcome and Introductions
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network
Moving Beyond Meaningful Use
Alexandra Mugge, MPH
Deputy Director, Division of Health Information Technology
Centers for Medicare & Medicaid Services
Panel Discussion - HIT: Readiness to Support Alternative Payment Models and Reporting for Precision Medicine and Quality Care
Panelists
- Amy Abernethy, MD, PhD
Flatiron Health - Jonathan Hirsch
Syapse - Michael Kolodziej, MD
Aetna, Inc. - Mia Levy, MD, PhD
Vanderbilt-Ingram Cancer Center - Alexandra Mugge, MPH
Centers for Medicare & Medicaid Services - Marcus Neubauer, MD
McKesson Specialty Health - Allen Roeseler
NantHealth - Bret Shillingstad, MD
Epic Systems Corporation
Moonshot Initiative
Gregory C. Simon
Executive Director
White House Cancer Task Force
Panel Discussion – Moonshot Initiative & The Role of HIT
Panelists
- Anthony Coletta, MD, MBA
Independence Blue Cross - Mia Levy, MD, PhD
Vanderbilt-Ingram Cancer Center - Edith Mitchell, MD
Sidney Kimmel Cancer Center at Jefferson - Michael Pellini, MD
Foundation Medicine - Allen Roeseler
NantHealth - Gregory C. Simon
White House Cancer Task Force
Lunch
Leveraging HIT to Improve Quality of Clinical Care
Lincoln Nadauld, MD, PhD
Medical Director of Cancer Genomics
Intermountain Healthcare
Panel Discussion – Issues, Opportunities, and Patient Impact
Panelists
- Amy Abernethy, MD, PhD
Flatiron Health - Stephen Edge, MD
Roswell Park Cancer Institute - Thomas Farrington
Prostate Health Education Network, Inc. - Linda House RN, BSN, MSM
Cancer Support Community - Lincoln Nadauld, MD, PhD
Intermountain Healthcare - Michael Pellini, MD
Foundation Medicine - Kyu Rhee, MD
IBM Corporation
Wrap-Up and Conclusions
For more information about the NCCN Oncology Policy Program and to register for the event, visit NCCN.org/policy.
###
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients. Media, visit NCCN.org/news.
[i] Agenda subject to change.
Katie Kiley Brown, NCCN
215.690.0238
Tags: